Flunarizine in Acute Ischemic Stroke: A pilot study

Completed

Phase 2 Results

Summary of Purpose

To evaluate the potential effectiveness of flunarazine in the acute stage of ischemic stroke in reducing death, functional impairment, and motor strength and improving quality of life.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 November 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Janssen Pharmaceutica

Trial Design

Randomized, double-bind, controlled trial of 26 patients.

Contacts

Not available